Acurx Pharmaceuticals, Inc. (ACXP): Price and Financial Metrics

Acurx Pharmaceuticals, Inc. (ACXP): $0.74

0.01 (-1.97%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add ACXP to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#200 of 330

in industry

ACXP Price/Volume Stats

Current price $0.74 52-week high $3.35
Prev. close $0.76 52-week low $0.68
Day low $0.71 Volume 149,000
Day high $0.76 Avg. volume 344,200
50-day MA $0.81 Dividend yield N/A
200-day MA $1.76 Market Cap 12.64M

ACXP Stock Price Chart Interactive Chart >


Acurx Pharmaceuticals, Inc. (ACXP) Company Bio


Acurx Pharmaceuticals, LLC, a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The company is also developing ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumoniae. The company was founded in 2017 and is based in Staten Island, New York.


ACXP Latest News Stream


Event/Time News Detail
Loading, please wait...

ACXP Latest Social Stream


Loading social stream, please wait...

View Full ACXP Social Stream

ACXP Price Returns

1-mo -16.19%
3-mo -55.69%
6-mo -68.24%
1-year -77.05%
3-year -81.95%
5-year N/A
YTD -9.09%
2024 -78.75%
2023 -3.77%
2022 -7.90%
2021 N/A
2020 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!